Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Point32Health | Hyperkalemia Agents | New policy |
| Aug 2, 2026 | Point32Health | Hyftor (sirolimus) | New policy |
| Aug 2, 2026 | Point32Health | Hyftor (sirolimus gel) | New policy |
| Aug 2, 2026 | Point32Health | Hetlioz (tasimelteon) | New policy |
| Aug 2, 2026 | Point32Health | Hetlioz (tasimelteon) | New policy |
| Aug 2, 2026 | Point32Health | Hereditary Angioedema Medications | New policy |
| Aug 2, 2026 | Point32Health | Hereditary Angioedema Medications | New policy |
| Aug 2, 2026 | Point32Health | Hemiclor (chlorthalidone) | New policy |
| Aug 2, 2026 | Point32Health | Hematinic Agents | New policy |
| Aug 2, 2026 | Point32Health | Harvoni (ledipasvir/sofosbuvir) | New policy |
| Aug 2, 2026 | Point32Health | HMG-CoA Reductase Inhibitors | New policy |
| Aug 2, 2026 | Point32Health | HIV Pre-Exposure Prophylaxis (PrEP) Medications | New policy |
| Aug 2, 2026 | Point32Health | Growth Hormones | New policy |
| Aug 2, 2026 | Point32Health | Growth Hormone Replacement Therapy | New policy |
| Aug 2, 2026 | Point32Health | Gonadotropins and Antigonadotropins | New policy |
| Aug 2, 2026 | Point32Health | Gonadotropin-releasing Hormone (GnRH) Agonists | New policy |
| Aug 2, 2026 | Point32Health | Gocovri (amantadine extended-release) | New policy |
| Aug 2, 2026 | Point32Health | Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists | New policy |
| Aug 2, 2026 | Point32Health | Glaucoma Step Therapy | New policy |
| Aug 2, 2026 | Point32Health | Glaucoma Medications | New policy |
| Aug 2, 2026 | Point32Health | Generic Metformin-Extended Release | New policy |
| Aug 2, 2026 | Point32Health | Generic Metformin Extended-Release | New policy |
| Aug 2, 2026 | Point32Health | Gastrointestinal Medications | New policy |
| Aug 2, 2026 | Point32Health | Gabapentin Medications | New policy |
| Aug 2, 2026 | Point32Health | Fluticasone propionate HFA Step Therapy Program | New policy |
| Aug 2, 2026 | Point32Health | Filsuvez (birch triterpenes) topical gel | New policy |
| Aug 2, 2026 | Point32Health | Filsuvez (birch triterpenes) topical gel | New policy |
| Aug 2, 2026 | Point32Health | Filspari (sparsentan) | New policy |
| Aug 2, 2026 | Point32Health | Filspari (sparsentan) | New policy |
| Aug 2, 2026 | Point32Health | Filgrastim Products | New policy |
| Aug 2, 2026 | Point32Health | Filgrastim Products | New policy |
| Aug 2, 2026 | Point32Health | Ferric Citrate (Auryxia) | New policy |
| Aug 2, 2026 | Point32Health | Fenofibrate Medications | New policy |
| Aug 2, 2026 | Point32Health | Febuxostat Step Therapy | New policy |
| Aug 2, 2026 | Point32Health | Febuxostat | New policy |
| Aug 2, 2026 | Point32Health | Fasenra (benralizumab) Pen (autoinjector) | New policy |
| Aug 2, 2026 | Point32Health | Fasenra (benralizumab) Pen (autoinjector) | New policy |
| Aug 2, 2026 | Point32Health | Fasenra (benralizumab) | New policy |
| Aug 2, 2026 | Point32Health | Ezetimibe/simvastatin | New policy |
| Aug 2, 2026 | Point32Health | Evrysdi (risdiplam) | New policy |
| Aug 2, 2026 | Point32Health | Evrysdi (risdiplam) | New policy |
| Aug 2, 2026 | Point32Health | Eucrisa (crisaborole) Step Therapy Program | New policy |
| Aug 2, 2026 | Point32Health | Epinephrine Auto-Injectors | New policy |
| Aug 2, 2026 | Point32Health | Epclusa (sofosbuvir/velpatasvir), Sofosbuvir/velpatasvir | New policy |
| Aug 2, 2026 | Point32Health | Entyvio Subcutaneous Products | New policy |
| Aug 2, 2026 | Point32Health | Endocrine Agents | New policy |
| Aug 2, 2026 | Point32Health | Endocrine Agents | New policy |
| Aug 2, 2026 | Point32Health | Endari (L-glutamine) | New policy |
| Aug 2, 2026 | Point32Health | Enbrel (etanercept) | New policy |
| Aug 2, 2026 | Point32Health | Ebglyss (lebrikizumab-lbkz) | New policy |